PAUL W SANDMAN Insider Trading $PDLI PDL BIOPHARMA, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL W SANDMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL W SANDMAN. PAUL W SANDMAN is EVP and General Counsel in BOSTON SCIENTIFIC CORP ($BSX) and SVP and General Counsel in BOSTON SCIENTIFIC CORP ($BSX) and Director in PDL BIOPHARMA, INC. ($PDLI).
PAUL W SANDMAN in PDL BIOPHARMA, INC.
Trading Symbol: PDLIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL W SANDMAN: Director
Holdings: 262,800 shares
Current Value: $580,788
Latest Transaction: Jun 24 2019
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PAUL W SANDMAN in PDL BIOPHARMA, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | Sandman Paul W | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
Jun 24 2019 | PDLI | PDL BIOPHARMA, INC ... | Sandman Paul W | Director | Option Exercise | A | 3.00 | 126,050 | 378,150 | 126,050 | |
Jun 12 2018 | PDLI | PDL BIOPHARMA, INC ... | Sandman Paul W | Director | Grant | A | 2.76 | 54,348 | 150,000 | 262,800 | 208.5 K to 262.8 K (+26.07 %) |
Jun 12 2017 | PDLI | PDL BIOPHARMA, INC ... | Sandman Paul W | Director | Grant | A | 2.47 | 60,729 | 150,001 | 208,452 | 147.7 K to 208.5 K (+41.11 %) |
Jun 03 2016 | PDLI | PDL BIOPHARMA, INC ... | Sandman Paul W | Director | Grant | A | 3.52 | 71,023 | 250,001 | 147,723 | 76.7 K to 147.7 K (+92.60 %) |
May 29 2015 | PDLI | PDL BIOPHARMA, INC ... | Sandman Paul W | Director | Grant | A | 6.80 | 22,059 | 150,001 | 76,700 | 54.6 K to 76.7 K (+40.37 %) |
Page: 1